IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+2.37%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
(+9.4%)
Cap. Flow
+$8.2M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
175
New
41
Increased
20
Reduced
27
Closed
26
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
$12.8M |
| 2 |
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
|
$11.2M |
| 3 |
89bio
ETNB
|
$8.73M |
| 4 |
IMAB
I-MAB
IMAB
|
$7.05M |
| 5 |
Immatics
IMTX
|
$6.77M |
Top Sells
| 1 |
Achieve Life Sciences
ACHV
|
$28.3M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.7M |
| 3 |
Adicet Bio
ACET
|
$14M |
| 4 |
Kura Oncology
KURA
|
$14M |
| 5 |
BioXcel Therapeutics
BTAI
|
$11.5M |
Sector Composition
| 1 | Healthcare | 96.72% |
| 2 | Industrials | 0% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Celldex Therapeutics
CLDX
$1.47B
| $21.8M | 1.58% | 1,469,730 -177,709 | -11% | -$2.64M |
|
2
KalVista Pharmaceuticals
KALV
$678M
| $15.6M | 1.13% | 1,235,471 +122,076 | +11% | +$1.54M |
|
3
Ocular Therapeutix
OCUL
$2.12B
| $13.1M | 0.95% | 1,716,293 -339,684 | -17% | -$2.58M |
|
|
4
Milestone Pharmaceuticals
MIST
$156M
| $12.8M | 0.92% | +1,743,545 | New | +$12.8M |
|
5
Protara Therapeutics
TARA
$120M
| $12.2M | 0.88% | 722,443 +194,479 | +37% | +$3.27M |
|
6
Immunovant
IMVT
$2.56B
| $11.3M | 0.82% | 321,887 +39,724 | +14% | +$1.4M |
|
|
TCON
7
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $11.2M | 0.81% | +2,162,549 | New | +$11.2M |
|
8
scPharmaceuticals
SCPH
$295M
| $11M | 0.8% | 1,481,147 +12,500 | +0.9% | +$93.1K |
|
9
Black Diamond Therapeutics
BDTX
$157M
| $10.9M | 0.79% | 358,941 +181,397 | +102% | +$5.48M |
|
|
10
89bio
ETNB
$1.34B
| $8.73M | 0.63% | +340,236 | New | +$8.73M |
|
11
Ardelyx
ARDX
$1.53B
| $8.04M | 0.58% | 1,530,436 +137,871 | +10% | +$724K |
|
12
Gossamer Bio
GOSS
$562M
| $7.23M | 0.52% | 582,494 -121,505 | -17% | -$1.51M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $7.1M | 0.51% | 116,151 -85,000 | -42% | -$5.2M |
|
|
SBBP
14
DELISTED
Strongbridge Biopharma plc.
SBBP
| $7.06M | 0.51% | 3,362,242 +91,004 | +3% | +$191K |
|
|
IMAB
15
I-MAB
IMAB
$340M
| $7.05M | 0.51% | +150,000 | New | +$7.05M |
|
|
CHMA
16
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $7.01M | 0.51% | 1,629,633 +200,000 | +14% | +$860K |
|
|
17
Immatics
IMTX
$619M
| $6.77M | 0.49% | +638,094 | New | +$6.77M |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.4M | 0.46% | +38,557 | New | +$6.4M |
|
|
ITCI
19
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.18M | 0.45% | 240,989 +233,787 | +3,246% | +$6M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $6.03M | 0.44% | +100,000 | New | +$6.03M |
|
|
WHWK
21
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $5.91M | 0.43% | +3,942,460 | New | +$5.91M |
|
22
Repare Therapeutics
RPTX
$71.7M
| $5.86M | 0.42% | +190,410 | New | +$5.86M |
|
23
Atara Biotherapeutics
ATRA
$84.6M
| $5.53M | 0.4% | +426,800 | New | +$5.53M |
|
|
CMPS
24
Compass Pathways
CMPS
$424M
| $5.34M | 0.39% | +153,048 | New | +$5.34M |
|
25
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $5.25M | 0.38% | 342,998 +314,724 | +1,113% | +$4.82M |
|